Researchers developed PRINCE, a small-molecule-controlled CRISPR system enabling precise, long-term regulation of gene editing. Its compact version, Little Prince, showed therapeutic potential in mouse models of cholesterol disease and macular degeneration. The post PRINCE: A Small-Molecule Switch for Safer Gene Editing appeared first on GEN - Genetic Engineering and Biotechnology News .